MAP2K7 and neoplasm: Moreover, it has been observed that MEK inhibition induced the accumulation of T cells within the tumor cells and the major histocompatibility complex (MHC) class I upregulation in mouse models, and synergized with immune checkpoints, promoting a sustainable tumor regression [40].